肺癌患者-话题@MedSci

#肺癌患者#

303篇内容 | 5549人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1990712, encodeId=3e931990e121a, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=让癌症患者“蒙在鼓里”更不利！二军大近3万肺癌患者研究, objectType=article, longId=192240, objectId=b1441922404b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1441922404b, replyNumber=0, likeNumber=64, createdTime=2020-06-01, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1441922404b, moduleTitle=让癌症患者“蒙在鼓里”更不利！二军大近3万肺癌患者研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1441922404b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990705, encodeId=2b281990e05fd, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Chest：六分钟步行试验对非小细胞肺癌患者术后心肺并发症的预测价值, objectType=article, longId=188667, objectId=f5e018866e94, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5e018866e94, replyNumber=0, likeNumber=62, createdTime=2020-12-18, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5e018866e94, moduleTitle=Chest：六分钟步行试验对非小细胞肺癌患者术后心肺并发症的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5e018866e94)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990706, encodeId=faff1990e066c, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=喜大普奔！中国PD-L1免疫疗法惠及III期肺癌患者，5年生存率或超50%, objectType=article, longId=189360, objectId=4814189360cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4814189360cb, replyNumber=0, likeNumber=63, createdTime=2020-12-12, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4814189360cb, moduleTitle=喜大普奔！中国PD-L1免疫疗法惠及III期肺癌患者，5年生存率或超50%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4814189360cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990710, encodeId=bdc11990e10ea, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=III期ADAURA试验：Tagrisso在EGFR突变型肺癌患者的辅助治疗中具有压倒性疗效, objectType=article, longId=192016, objectId=e03e1920168c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e03e1920168c, replyNumber=0, likeNumber=57, createdTime=2020-06-28, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e03e1920168c, moduleTitle=III期ADAURA试验：Tagrisso在EGFR突变型肺癌患者的辅助治疗中具有压倒性疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e03e1920168c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990685, encodeId=3f50199068584, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Lancet oncol：阿特珠单抗联合化疗作为非鳞状非小细胞肺癌患者一线疗法的疗效和安全性, objectType=article, longId=166796, objectId=7baf166e96c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7baf166e96c9, replyNumber=0, likeNumber=78, createdTime=2020-01-28, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7baf166e96c9, moduleTitle=Lancet oncol：阿特珠单抗联合化疗作为非鳞状非小细胞肺癌患者一线疗法的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7baf166e96c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990693, encodeId=7a7e199069327, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=SCLC二线治疗三大药物造福小细胞肺癌患者, objectType=article, longId=175993, objectId=64a41e5993d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64a41e5993d6, replyNumber=0, likeNumber=70, createdTime=2019-12-20, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64a41e5993d6, moduleTitle=SCLC二线治疗三大药物造福小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64a41e5993d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990688, encodeId=c65c19906880c, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Chest：肌肉减少症在肺癌患者中的预后价值, objectType=article, longId=167769, objectId=da2016e769fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da2016e769fc, replyNumber=0, likeNumber=89, createdTime=2019-12-21, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da2016e769fc, moduleTitle=Chest：肌肉减少症在肺癌患者中的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da2016e769fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990684, encodeId=c8bb1990684e2, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JCO：局部巩固疗法与维持治疗或观察对低变应性非小细胞肺癌患者的效果, objectType=article, longId=165945, objectId=10d1165945f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d1165945f6, replyNumber=0, likeNumber=70, createdTime=2020-03-17, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d1165945f6, moduleTitle=JCO：局部巩固疗法与维持治疗或观察对低变应性非小细胞肺癌患者的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d1165945f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990675, encodeId=0f1b19906e5a1, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=又一城市正式执行4+7带量采购肺癌患者得享百元救命药, objectType=article, longId=163446, objectId=aca81634469b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aca81634469b, replyNumber=0, likeNumber=89, createdTime=2019-04-28, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aca81634469b, moduleTitle=又一城市正式执行4+7带量采购肺癌患者得享百元救命药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aca81634469b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990681, encodeId=48c71990681af, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=PLOS ONE：肺癌患者的氧化应激与脂质代谢的血清标志物改变有关, objectType=article, longId=164253, objectId=706e16425344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=706e16425344, replyNumber=0, likeNumber=68, createdTime=2020-01-12, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=706e16425344, moduleTitle=PLOS ONE：肺癌患者的氧化应激与脂质代谢的血清标志物改变有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=706e16425344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990703, encodeId=72661990e03b4, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=Sci Rep：非小细胞肺癌患者全身治疗对脑转移的影响, objectType=article, longId=184786, objectId=dab2184e86b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dab2184e86b5, replyNumber=0, likeNumber=74, createdTime=2020-08-31, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dab2184e86b5, moduleTitle=Sci Rep：非小细胞肺癌患者全身治疗对脑转移的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dab2184e86b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990702, encodeId=db121990e0210, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=关爱每一位肺癌患者，注重疗效更要关注生活质量, objectType=article, longId=183973, objectId=72371839e35d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72371839e35d, replyNumber=0, likeNumber=79, createdTime=2020-04-11, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72371839e35d, moduleTitle=关爱每一位肺癌患者，注重疗效更要关注生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72371839e35d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990687, encodeId=8cc6199068e1e, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=无法手术的晚期肺癌患者生存结果大不同——局部晚期&转移性晚期肺癌, objectType=article, longId=167387, objectId=5acb16e38737, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acb16e38737, replyNumber=0, likeNumber=70, createdTime=2019-08-25, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acb16e38737, moduleTitle=无法手术的晚期肺癌患者生存结果大不同——局部晚期&转移性晚期肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acb16e38737)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990676, encodeId=663219906e6cc, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果, objectType=article, longId=163563, objectId=b02416356319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b02416356319, replyNumber=0, likeNumber=76, createdTime=2019-10-06, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b02416356319, moduleTitle=百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b02416356319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990690, encodeId=1d4a1990690c7, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JACC：肺癌患者心脏辐射剂量与不良预后相关, objectType=article, longId=169055, objectId=3871169055d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3871169055d1, replyNumber=0, likeNumber=79, createdTime=2019-08-29, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3871169055d1, moduleTitle=JACC：肺癌患者心脏辐射剂量与不良预后相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3871169055d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990680, encodeId=3357199068026, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=拜耳公布larotrectinib治疗NTRK基因融合阳性转移性非小细胞肺癌患者的亚组分析结果, objectType=article, longId=164175, objectId=36571641e5d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36571641e5d2, replyNumber=0, likeNumber=0, createdTime=2019-10-11, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36571641e5d2, moduleTitle=拜耳公布larotrectinib治疗NTRK基因融合阳性转移性非小细胞肺癌患者的亚组分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36571641e5d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990697, encodeId=4b5d199069eb4, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JAMA Oncology：二甲双胍抗癌实锤！临床试验证实，二甲双胍+靶向药一线治疗，可将携带EGFR突变晚期肺癌患者的生存期延长14个月, objectType=article, longId=180022, objectId=5bda180022ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bda180022ac, replyNumber=0, likeNumber=88, createdTime=2019-11-18, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bda180022ac, moduleTitle=JAMA Oncology：二甲双胍抗癌实锤！临床试验证实，二甲双胍+靶向药一线治疗，可将携带EGFR突变晚期肺癌患者的生存期延长14个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bda180022ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990686, encodeId=9d32199068602, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=ASCO2019l非小细胞肺癌患者存活率与免疫治疗颅内放疗的比较分析, objectType=article, longId=167234, objectId=43c216e2347a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43c216e2347a, replyNumber=0, likeNumber=72, createdTime=2019-11-05, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43c216e2347a, moduleTitle=ASCO2019l非小细胞肺癌患者存活率与免疫治疗颅内放疗的比较分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43c216e2347a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990694, encodeId=62d019906949d, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JAMA Surg：手术中先连接出血静脉可降低非小细胞肺癌患者肿瘤细胞的传播, objectType=article, longId=177462, objectId=a42e1e746250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a42e1e746250, replyNumber=0, likeNumber=75, createdTime=2019-11-19, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a42e1e746250, moduleTitle=JAMA Surg：手术中先连接出血静脉可降低非小细胞肺癌患者肿瘤细胞的传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a42e1e746250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1990678, encodeId=e34319906e8a4, content=<a href='/topic/show?id=5739822223f' target=_blank style='color:#2F92EE;'>#肺癌患者#</a>, objectTitle=JAMA：非小细胞肺癌患者肿瘤突变特征与预后, objectType=article, longId=164014, objectId=89d116401491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d116401491, replyNumber=0, likeNumber=75, createdTime=2020-03-11, rootId=0, userName=gds2009, userId=f612331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d116401491, moduleTitle=JAMA：非小细胞肺癌患者肿瘤突变特征与预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d116401491)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺癌患者

2020-05-29

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

让癌症患者“蒙在鼓里”更不利！二军大近3万肺癌患者研究

2020-06-01

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Chest：六分钟步行试验对非小细胞肺癌患者术后心肺并发症的预测价值

2020-12-18

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

喜大普奔！中国PD-L1免疫疗法惠及III期肺癌患者，5年生存率或超50%

2020-12-12

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

III期ADAURA试验：Tagrisso在EGFR突变型肺癌患者的辅助治疗中具有压倒性疗效

2020-06-28

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Lancet oncol：阿特珠单抗联合化疗作为非鳞状非小细胞肺癌患者一线疗法的疗效和安全性

2020-01-28

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

SCLC二线治疗三大药物造福小细胞肺癌患者

2019-12-20

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Chest：肌肉减少症在肺癌患者中的预后价值

2019-12-21

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JCO：局部巩固疗法与维持治疗或观察对低变应性非小细胞肺癌患者的效果

2020-03-17

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

又一城市正式执行4+7带量采购肺癌患者得享百元救命药

2019-04-28

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

PLOS ONE：肺癌患者的氧化应激与脂质代谢的血清标志物改变有关

2020-01-12

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

Sci Rep：非小细胞肺癌患者全身治疗对脑转移的影响

2020-08-31

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

关爱每一位肺癌患者，注重疗效更要关注生活质量

2020-04-11

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

无法手术的晚期肺癌患者生存结果大不同——局部晚期&转移性晚期肺癌

2019-08-25

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

百时美施贵宝公布欧狄沃（纳武利尤单抗注射液）治疗经治非小细胞肺癌患者的长期生存汇总分析结果

2019-10-06

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JACC：肺癌患者心脏辐射剂量与不良预后相关

2019-08-29

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

拜耳公布larotrectinib治疗NTRK基因融合阳性转移性非小细胞肺癌患者的亚组分析结果

2019-10-11

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JAMA Oncology：二甲双胍抗癌实锤！临床试验证实，二甲双胍+靶向药一线治疗，可将携带EGFR突变晚期肺癌患者的生存期延长14个月

2019-11-18

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

ASCO2019l非小细胞肺癌患者存活率与免疫治疗颅内放疗的比较分析

2019-11-05

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JAMA Surg：手术中先连接出血静脉可降低非小细胞肺癌患者肿瘤细胞的传播

2019-11-19

gds2009 (审核中...)

前往app查看评论内容

#肺癌患者#

JAMA：非小细胞肺癌患者肿瘤突变特征与预后

2020-03-11

科室
- - 订阅+
  - 更多科室
工具
服务